Treatment of central serous chorioretinopathy with topical NSAIDs

Clicks: 369
ID: 7367
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #5 of 32 articles by views in clinical ophthalmology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Treatment of central serous chorioretinopathy with topical NSAIDs Sepehr Bahadorani,1 Kyle Maclean,1 Kendall Wannamaker,1 Edward Rickie Chu,1 Nathan Gresores,2 Jeong-Hyeon Sohn,1 Roberto Diaz-Rohena,1 Michael A Singer21Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; 2Medical Center Ophthalmology Associates, San Antonio, TX, USACorrespondence: Michael A SingerMedical Center Ophthalmology Associates, 9157 Huebner Road, San Antonio, TX 78240, USA Tel +1 210 697 2020 Email msinger
Reference Key
bahadorani2019treatmentclinical Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sepehr Bahadorani;Kyle Maclean;Kendall Wannamaker;Edward Rickie Chu;Nathan Gresores;Jeong­-Hyeon Sohn;Roberto Diaz­-Rohena;Michael A Singer;
Journal clinical ophthalmology
Year 2019
DOI
10.2147/OPTH.S202047
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.